# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-17-008187
Filing Date
2017-05-08
Accepted
2017-05-05 17:42:06
Documents
66
Period of Report
2016-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K/A | atrn20170503_10ka.htm | 10-K/A | 1749535
2 | EXHIBIT 10.16 | ex10-16.htm | EX-10.16 | 50748
3 | EXHIBIT 14.1 | ex14-1.htm | EX-14.1 | 75019
4 | EXHIBIT 14.2 | ex14-2.htm | EX-14.2 | 45989
5 | EXHIBIT 14.3 | ex14-3.htm | EX-14.3 | 5805
6 | EXHIBIT 23.1 | ex23-1.htm | EX-23.1 | 3518
7 | EXHIBIT 31.2 | ex31-2.htm | EX-31.2 | 23971
8 | EXHIBIT 32.1 | ex32-1.htm | EX-32.1 | 13063
9 | EXHIBIT 99.1 | ex99-1.htm | EX-99.1 | 17849
| Complete submission text file | 0001437749-17-008187.txt |  | 6328079

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | EXHIBIT 101.INS | ptix-20161231.xml | EX-101.INS | 958317
11 | EXHIBIT 101.SCH | ptix-20161231.xsd | EX-101.SCH | 58680
12 | EXHIBIT 101.CAL | ptix-20161231_cal.xml | EX-101.CAL | 24797
13 | EXHIBIT 101.DEF | ptix-20161231_def.xml | EX-101.DEF | 480800
14 | EXHIBIT 101.LAB | ptix-20161231_lab.xml | EX-101.LAB | 357048
15 | EXHIBIT 101.PRE | ptix-20161231_pre.xml | EX-101.PRE | 487027

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51353 | Film No.: 17819667
SIC: 7389 Services-Business Services, NEC